Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-138,352
Closed -$923K 14
2025
Q3
$923K Hold
138,352
0.82% 8
2025
Q2
$955K Hold
138,352
0.69% 9
2025
Q1
$935K Hold
138,352
1% 7
2024
Q4
$1.03M Hold
138,352
0.91% 2
2024
Q3
$722K Hold
138,352
0.49% 5
2024
Q2
$753K Hold
138,352
0.6% 3
2024
Q1
$899K Hold
138,352
0.63% 2
2023
Q4
$1.06M Hold
138,352
0.72% 2
2023
Q3
$826K Hold
138,352
0.91% 2
2023
Q2
$1.69M Sell
138,352
-1
-0% -$13 1.66% 2
2023
Q1
$2.44M Hold
138,353
2.26% 2
2022
Q4
$7.19M Hold
138,353
7.17% 3
2022
Q3
$11.6M Hold
138,353
8.3% 2
2022
Q2
$20.1M Hold
138,353
11.82% 2
2022
Q1
$21.4M Hold
138,353
10.81% 3
2021
Q4
$38.1M Buy
+138,353
New +$63.9M 32.29% 1

Greycroft's NEUE Position: Q4 2025 in Review

Greycroft sold out of NeueHealth (NEUE) in Q4 2025, closing a stake of 138,352 shares — an estimated $923K sold.

Greycroft first reported a position in NEUE in Q4 2021 and held it in 16 quarters. The position peaked at $38.1M in Q4 2021. 0 funds tracked by Wall St. Rank hold NEUE as of Q4 2025.

  • Greycroft reported no remaining NeueHealth position as of Q4 2025 after selling out during the quarter.
  • Greycroft sold 138,352 NeueHealth shares in Q4 2025, an estimated $923K.
  • Greycroft first reported a position in NeueHealth in Q4 2021 and held it in 16 quarters.
  • Greycroft's NeueHealth position peaked at $38.1M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held NeueHealth as of Q4 2025.

Based on Greycroft's 13F filing for Q4 2025, filed 17 Feb 2026.